MS

Mohammed Siraj Uddin

Active Director Director DIN 03447765
DIN 03447765 First appointment Mar 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2011
Shareholding value •••• Premium profile

About Mohammed Siraj Uddin

Data last updated:

Mohammed Siraj Uddin is a Director at Granvalor Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Granvalor Pharmaceuticals Private Limited reported revenue of ₹2.14 Cr (FY 2025).

DIN 03447765
Primary Designation Director
Industry Pharma
First Appointment 25 Mar 2011
Oldest Company Age 15 yrs
Largest company Granvalor Pharmaceuticals Private Limited · ₹2.14 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Mar 20112011₹2.14 Cr (FY 2025)Active

Board colleagues of Mohammed Siraj Uddin

NameDINCompanyDesignation
Khaja Aliuddin03447759Granvalor Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Granvalor Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohammed Siraj Uddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Siraj Uddin

Mohammed Siraj Uddin currently holds 1 directorship: Granvalor Pharmaceuticals Private Limited (Director, since 25 Mar 2011, revenue ₹2.14 Cr (FY 2025)).

Mohammed Siraj Uddin was first appointed on 25 Mar 2011 as Director at Granvalor Pharmaceuticals Private Limited.

The current boards of Mohammed Siraj Uddin's companies include Khaja Aliuddin (Granvalor Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available